Literature DB >> 12009094

Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?

Toshiyuki Kunisada1, Jane M Moseley, John L Slavin, T John Martin, Peter F M Choong.   

Abstract

AIM: Parathyroid hormone-related protein (PTHrP) is one of the critical factors for the differentiation and growth of chondrocytes. We examined the correlation between the co-expression of PTHrP and PTH/PTHrP receptor and the grade of malignancy in cartilaginous tumours.
METHODS: We analysed PTHrP and PTH/PTHrP receptor expression in chondrosarcoma by immunohistochemistry and compared specific staining with the expression in benign cartilaginous tumours. There were 38 cartilaginous bone tumours consisting of 26 chondrosarcoma, six enchondroma and six osteochondroma. Chondrosarcoma were composed of 20 conventional chondrosarcoma (10 grade 1, seven grade 2, and three grade 3), two dedifferentiated chondrosarcoma, two clear cell chondrosarcoma, and two myxoid chondrosarcoma. We performed the standard peroxidase-labelled streptavidin-biotin detection method for immunohistochemistry using an antibody raised against PTHrP (1-14) and PTH/PTHrP receptor. The magnitude of receptor positivity of PTHrP and PTH/ PTHrP in each tumour was assessed as a percentage of PTHrP and PTH/PTHrP-positive cells per thousand tumour cells in the most histologically aggressive area of the tumour.
RESULTS: All chondrosarcoma, five of six enchondroma, and four of six osteochondroma showed PTHrP-positive cells, and all chondrosarcoma, five of six enchondroma and five of six osteochondroma showed PTHrP receptor-positive cells. The grade of malignancy correlated with the percentage of both PTHrP and PTH/PTHrP receptor-positive tumour cells (P < 0.0001, either). Each grade of chondrosarcoma showed statistically higher expression of both PTHrP and PTH/PTHrP receptor than benign cartilaginous tumour.
CONCLUSION: This is the first report of the co-expression of PTHrP and PTH/PTHrP receptor in chondrosarcoma. PTHrP and PTH/PTHrP receptor positivity may be valuable for differentiating between benign and malignant cartilaginous tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009094     DOI: 10.1080/003130201201117936

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  11 in total

Review 1.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

2.  Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.

Authors:  Tri Dung Tiet; Sevan Hopyan; Puviindran Nadesan; Nalan Gokgoz; Raymond Poon; Alvin C Lin; Taiqiang Yan; Irene L Andrulis; Benjamin A Alman; Jay S Wunder
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

3.  The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.

Authors:  Liesbeth Hameetman; Petra Kok; Paul H C Eilers; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2005-03-03       Impact factor: 4.064

4.  Chondrosarcoma cell differentiation.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

5.  Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer.

Authors:  Zi-Jun Zhen; Jia-Yu Ling; Yue Cai; Wen-Biao Luo; You-Jian He
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

6.  Indian hedgehog signaling pathway differences between swarm rat chondrosarcoma and native rat chondrocytes.

Authors:  George S Oji; Pablo Gomez; Gail Kurriger; Jeff Stevens; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2007

7.  PTHR1 mutations associated with Ollier disease result in receptor loss of function.

Authors:  Alain Couvineau; Vinciane Wouters; Guylène Bertrand; Christiane Rouyer; Bénédicte Gérard; Laurence M Boon; Bernard Grandchamp; Miikka Vikkula; Caroline Silve
Journal:  Hum Mol Genet       Date:  2008-06-17       Impact factor: 6.150

Review 8.  Ollier disease.

Authors:  Caroline Silve; Harald Jüppner
Journal:  Orphanet J Rare Dis       Date:  2006-09-22       Impact factor: 4.123

9.  Chondrosarcoma and peroxisome proliferator-activated receptor.

Authors:  K Nishida; T Kunisada; Z N Shen; Y Kadota; K Hashizume; T Ozaki
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

Review 10.  The Role of Hedgehog Signaling in Tumor Induced Bone Disease.

Authors:  Shellese A Cannonier; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2015-08-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.